Tuesday, November 12, 2013
FDA-Approved Drug Labels, Pharmacogenomics and PharmGKB Evaluation
›
FDA-approved drug label standardization and pharmacogenomics People often use the wording "FDA drug labels" instead of "FDA-...
Monday, October 28, 2013
Viva La Evidence
›
We came across this brilliant music video “ Viva La Evidence ” by Dr. James McCormack. It’s a parody of Coldplay's Viva La Vida and th...
Sunday, October 20, 2013
Venlafaxine Pathway published in PG&G
›
Venlafaxine is a s erotonin-norepinephrine reuptake inhibitor (SNRI) marketed for the treatment of depression disorders. We recen...
Thursday, October 17, 2013
NIH funds ClinGen: a resource to establish which genetic variants are clinically relevant
›
The NIH ( NHGRI and NICHD ) has awarded more than $25 million over the course of 4 years for the development of the Clinical Genom...
Tuesday, October 15, 2013
The Curation Economy
›
In an October 7th article in The Huffington Post blog section , Steve Rosenbaum discusses the development of a so-called "Curation Econ...
Sunday, October 6, 2013
CPIC publishes guidelines for IFNL3 (IL28B) and peginterferon alpha based regimens
›
Guidelines regarding the use of IFNL3 (formerly known as IL28B ) genotypes in peginterferon alpha based therapies have been accepted for pu...
Monday, September 23, 2013
CYP2D6 genotype and tamoxifen response: meta-analysis of heterogeneous population
›
Tamoxifen treatment results in substantial inter-individual variability of outcome, possibly due to genetic variability in CYP2D6. ...
‹
›
Home
View web version